Top View
- BRAJDC Protocol
- Original Article Docetaxel, 5-Fluorouracil, and Leucovorin As
- CY 2012 CDER Fast Track Calendar Year Approvals* Data As of 12-31-2012 Total of 20 Approvals
- 8. Malignant Disease and Immunosuppression
- Docetaxel-Fluorouracil-Folinic Acid-Oxaliplatin (FLOT)
- Chemotherapy Regimen: TC
- HOPA News Volume 10, Issue 1
- Phase I Study of Docetaxel, Cisplatin, and 5-Fluorouracil Chemoradiotherapy for Local Or Metastatic Esophageal Cancer
- Chemotherapy Protocol HEAD and NECK CANCER CISPLATIN (75)
- Mechanisms of Taxane Resistance
- Emetogenic Potential of Antineoplastic Agents
- Characteristics of Preapproval and Postapproval Studies for Drugs Granted Accelerated Approval by the US Food and Drug Administration
- Docetaxel for Breast Cancer Treatment-Side Effects on Ocular Surface, a Systematic Review
- Computationally Predicting Clinical Drug Combination Efficacy With
- Breast Pathway Group– TC (Docetaxel / Cyclophosphamide) in Early Breast Cancer
- Handling Cytostatic Drugs: Contents
- (PDF) Download
- TAXOTERE: TAXOTERE Safely and Effectively
- Chemo-Sensitivity of Two-Dimensional Monolayer And
- Doxorubicin and Cyclophosphamide Followed by Docetaxel
- BRLAACD Protocol
- Role of Tumor Necrosis Factor Alpha-Induced Protein 1 in Paclitaxel Resistance
- Capecitabine in Combination with Docetaxel and Mitomycin C in Patients with Pre-Treated Tumours: Results of an Extended Phase-I Trial
- Telling Cells How to Die Docetaxel Therapy in Cancer Cell Lines
- TAXOTERE (Docetaxel) Injection, for Intravenous Use Cisplatin Infusion; for 4 Cycles (2.5) Initial U.S
- Participation of Autophagy in the Cytotoxicity Against Breast Cancer Cells by Cisplatin
- Gastric Cancer Treatment Regimens
- HEAD and NECK CANCER TREATMENT REGIMENS (Part 1 of 5)
- Drug Properties Paclitaxel (Taxol) Is Highly Lipophilic and Requires
- Clinical Challenges in Caring for Patients with Diabetes and Cancer
- Guidelines for the Use of Anti-Emetics with Chemotherapy
- Outcome of Combination Chemotherapy with Docetaxel
- DBL™ Docetaxel Injection, Concentrated Injection
- Targeting Aurora Kinase with MK-0457 Inhibits Ovarian Cancer Growth Yvonne G
- HNLADCF Protocol
- And Taxane-Pretreated Metastatic Breast Cancer
- Docetaxel – Cyclophosphamide Q21DAYS
- DOCETAXEL INJECTION Safely and Effectively
- Docetaxel-Cyclophosphamide-TC-Breast-Protocol-BOO2-CRP09-V1.5.Pdf
- TAXOTERE Safely and Effectively
- Anti-Microtubule Drugs
- Hazardous Drug List
- Docetaxel and Cyclophosphamide (Breast)
- CE SESHP Chemo Agents
- Radiation Recall Phenomenon Associated with Arsenic Trioxide
- Boards Fodder DIRECTIONS RESIDENCY In
- Pertuzumab, Trastuzumab, Docetaxel and Carboplatin
- Paclitaxel and Docetaxel Enhance the Metabolism of Doxorubicin to Toxic Species in Human Myocardium1
- Four Cycles of Docetaxel-Cyclophosphamide
- Anticancer Dose Adjustment for Patients with Renal and Hepatic Dysfunction: from Scientific Evidence to Clinical Application
- Combinations of an Anti-HER2 Antibody-Drug Conjugate and Docetaxel
- Chemosensitivity Testing of Paclitaxel Versus Docetaxel in Human Gynecological Carcinomas: a Comparison with Carboplatin